A retrospective study assessing efficacy and safety of low dose radiotherapy plus Immune checkpoint inhibitors in patients with extended stage Small cell lung cancer
Latest Information Update: 21 Jun 2020
At a glance
- Drugs Durvalumab (Primary) ; Ipilimumab (Primary) ; Nivolumab (Primary) ; Pembrolizumab (Primary) ; Sintilimab (Primary) ; Cisplatin; Etoposide; Paclitaxel
- Indications Small cell lung cancer
- Focus Therapeutic Use
Most Recent Events
- 21 Jun 2020 New trial record
- 31 May 2020 Results presented at the 56th Annual Meeting of the American Society of Clinical Oncology